Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome

Παρόμοια τεκμήρια

• Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
  ανά: Vyas, P, κ.ά.
  Έκδοση: (2007)
• Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
  ανά: Bhatnagar, N, κ.ά.
  Έκδοση: (2016)
• Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
  ανά: Roy, A, κ.ά.
  Έκδοση: (2009)
• Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
  ανά: Norton, A, κ.ά.
  Έκδοση: (2007)
• Natural history of GATA-1 mutations in Down syndrome.
  ανά: Ahmed, M, κ.ά.
  Έκδοση: (2003)